GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eviana Health Corp (XCNQ:EHC) » Definitions » Short-Term Debt

Eviana Health (XCNQ:EHC) Short-Term Debt : C$0.00 Mil (As of Mar. 2019)


View and export this data going back to 2017. Start your Free Trial

What is Eviana Health Short-Term Debt?

Eviana Health's Short-Term Debt for the quarter that ended in Mar. 2019 was C$0.00 Mil.

Eviana Health's annual Short-Term Debt declined from Jun. 2016 (C$0.23 Mil) to Jun. 2017 (C$0.00 Mil) but then stayed the same from Jun. 2017 (C$0.00 Mil) to Jun. 2018 (C$0.00 Mil).


Eviana Health Short-Term Debt Historical Data

The historical data trend for Eviana Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eviana Health Short-Term Debt Chart

Eviana Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18
Short-Term Debt
- 0.23 - -

Eviana Health Quarterly Data
Jun15 Mar16 Jun16 Sep16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Eviana Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Eviana Health Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Eviana Health's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Eviana Health (XCNQ:EHC) Business Description

Traded in Other Exchanges
N/A
Address
5728 East Boulevard, Vancouver, BC, CAN, V6M 4M4
Eviana Health Corp produces and sells cannabinoid products from natural hemp strains of cannabis sativa for consumer health-care products, pharmaceuticals, nutraceuticals, and cosmeceuticals, as well as for topical creams and other health and wellness products.